In addition, when compared to co-incubation with the inhibitor alone, the infection rate of either JAK1 or STAT1 inhibitor treatment was significantly higher without RNase 7 pretreatment (p < 0.01, compared to AMP plus JAK1 or STAT1 inhibitor treatment, respectively). The gene discussed is RNASE7; the disease is infection.